Ketoanalogue Review: New Update on an Old Therapy

The prevalence and incidence of chronic kidney disease (CKD) in the United States is problematic with an estimated thirty million people with CKD; the equivalence of 15% of the adult population.1 Treatment of CKD is a multifactorial approach as is the nutritional management. While the nutritional components have historically sparked multiple debates and scrutiny, the discussion of protein influence on CKD has recently gained heightened interest. Reduction of protein intake has long been established to slow the progression of CKD.